Latest stories on RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results
PR Newswire50 · neutralgeneral
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR Newswire50 · neutralgeneral
Rigel Appoints Alison Hannah as New Chief Medical Officer
TipRanks56 · neutralgeneral
RIGEL PHARMACEUTICALS INC (RIGL) files 8-K
SEC 8-K50 · neutralgeneral
Rigel appoints Alison L. Hannah as chief medical officer
Seeking Alpha55 · neutralgeneral
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer
PR Newswire59 · neutralgeneral
A Look At The Transformation Around Rigel Pharmaceuticals
Seeking Alpha58 · neutralproduct/pr
Rigel Expands Oncology Portfolio with VEPPANU Global Rights
TipRanks63 · neutralproduct/pr
RIGEL PHARMACEUTICALS INC (RIGL) files 8-K
SEC 8-K50 · neutralgeneral
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
PR Newswire59 · neutralgeneral
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) | RIGL Stock News
StockTitan67 · bullishproduct/pr
Rigel to Present at the Jefferies Global Healthcare Conference
PR Newswire56 · neutralgeneral
Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News
StockTitan55 · neutralgeneral
Lilly and Rigel Advance RA Pipeline as Key LY3871801 Mid-Stage Trial Reaches Completion
TipRanks63 · neutralproduct/pr
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress | RIGL Stock News
StockTitan73 · bullishproduct/pr
RIGL: [8-K] RIGEL PHARMACEUTICALS INC Reports Material Event
StockTitan SEC50 · neutralgeneral
Rigel Pharmaceuticals Highlights Growth Amid Rising Costs
TipRanks56 · neutralearnings
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer
Yahoo Top67 · bullishm&a
Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference
PR Newswire55 · neutralgeneral
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
Yahoo Top56 · neutralanalyst
Rigel Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings